rs61749337
Positions:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_001031685.3(TP53BP2):c.566C>T(p.Ala189Val) variant causes a missense change. The variant allele was found at a frequency of 0.0118 in 1,614,044 control chromosomes in the GnomAD database, including 156 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0087 ( 6 hom., cov: 32)
Exomes 𝑓: 0.012 ( 150 hom. )
Consequence
TP53BP2
NM_001031685.3 missense
NM_001031685.3 missense
Scores
4
11
Clinical Significance
Conservation
PhyloP100: 6.60
Genes affected
TP53BP2 (HGNC:12000): (tumor protein p53 binding protein 2) This gene encodes a member of the ASPP (apoptosis-stimulating protein of p53) family of p53 interacting proteins. The protein contains four ankyrin repeats and an SH3 domain involved in protein-protein interactions. It is localized to the perinuclear region of the cytoplasm, and regulates apoptosis and cell growth through interactions with other regulatory molecules including members of the p53 family. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0067211688).
BP6
Variant 1-223804257-G-A is Benign according to our data. Variant chr1-223804257-G-A is described in ClinVar as [Benign]. Clinvar id is 788949.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 6 gene
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TP53BP2 | ENST00000343537.12 | c.566C>T | p.Ala189Val | missense_variant | 6/18 | 1 | NM_001031685.3 | ENSP00000341957.7 | ||
TP53BP2 | ENST00000391878.6 | c.179C>T | p.Ala60Val | missense_variant | 7/19 | 1 | ENSP00000375750.2 | |||
TP53BP2 | ENST00000494100.1 | c.365C>T | p.Ala122Val | missense_variant | 4/5 | 3 | ENSP00000420225.1 | |||
TP53BP2 | ENST00000496282.5 | n.459C>T | non_coding_transcript_exon_variant | 5/5 | 3 |
Frequencies
GnomAD3 genomes AF: 0.00876 AC: 1333AN: 152174Hom.: 6 Cov.: 32
GnomAD3 genomes
AF:
AC:
1333
AN:
152174
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00890 AC: 2237AN: 251302Hom.: 20 AF XY: 0.00885 AC XY: 1202AN XY: 135820
GnomAD3 exomes
AF:
AC:
2237
AN:
251302
Hom.:
AF XY:
AC XY:
1202
AN XY:
135820
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0121 AC: 17686AN: 1461752Hom.: 150 Cov.: 31 AF XY: 0.0117 AC XY: 8483AN XY: 727162
GnomAD4 exome
AF:
AC:
17686
AN:
1461752
Hom.:
Cov.:
31
AF XY:
AC XY:
8483
AN XY:
727162
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00875 AC: 1332AN: 152292Hom.: 6 Cov.: 32 AF XY: 0.00782 AC XY: 582AN XY: 74458
GnomAD4 genome
AF:
AC:
1332
AN:
152292
Hom.:
Cov.:
32
AF XY:
AC XY:
582
AN XY:
74458
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
54
ALSPAC
AF:
AC:
71
ESP6500AA
AF:
AC:
13
ESP6500EA
AF:
AC:
117
ExAC
AF:
AC:
1001
Asia WGS
AF:
AC:
5
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
TP53BP2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 20, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
Eigen
Benign
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
PrimateAI
Benign
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Benign
T;T
Sift4G
Benign
T;T
Vest4
MVP
MPC
0.70
ClinPred
T
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at